home · filing · 0001493152-23-003966
8-K
filed February 8, 2023, 6:59 PM ET
ticker PALI
CIK 0001357459
leadership
confidence high
sentiment neutral
materiality 0.50
Palisade Bio promotes Robert McRae to COO, appoints J.D. Finley to Board
PALISADE BIO, INC.
Robert McRae appointed COO effective Feb 2, 2023; previously SVP of Operations and Strategic Development.
J.D. Finley (interim CEO/CFO) appointed to Board as Class III director, expanding board from 7 to 8.
Finley's base salary raised to $490K (from $440K) and target bonus increased to 45%, effective Oct 1, 2022.
Conditional equity grants to officers: 81,500 options ($2.40, 10yr), 59,500 RSUs, 68,700 PSUs; require shareholder approval.
PSUs vest 50% at $3.20 VWAP and 50% at $4.25 VWAP over 20 consecutive trading days.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Robert McRae
Chief Operating Officer
PALI ·
PALISADE BIO, INC.
Effective 2023-02-02
Filed February 8, 2023, 6:59 PM ET
On February 2, 2023, the Company appointed Robert McRae as the Company’s Chief Operating Officer.
Appointed
J.D. Finley
Director
PALI ·
PALISADE BIO, INC.
Effective 2023-02-02
Filed February 8, 2023, 6:59 PM ET
On February 2, 2023, the Board appointed J.D. Finley to the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert McRae was appointed as Chief Operating Officer at PALISADE BIO, INC..
Action appointed
Role Chief Operating Officer
Exact text from the filing
On February 2, 2023, the Company appointed Robert McRae as the Company’s Chief Operating Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
J.D. Finley was appointed as Director at PALISADE BIO, INC..
Action appointed
Role Director
Exact text from the filing
On February 2, 2023, the Board appointed J.D. Finley to the Board.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-23-003966
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.